Millipore Launches MILLIPLEX™ MAP
Billerica, Massachusetts—March 07, 2008— Millipore Corporation, a Life Science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today announced the launch of its MILLIPLEX MAP (multi-analyte profiling) portfolio. For the first time, two industry-leading product lines, Beadlyte® and LINCOplex®, are combined in this single, comprehensive kit, presenting the newest and best thinking from the world’s first multiplexing leaders.
MILLIPLEX MAP is the best-quality multiplex kit on the market, displaying the greatest lot-to-lot consistency with uniform analyte profiles irrespective of plex size. To verify this consistency, Millipore provides quality controls with each kit. Millipore’s standards validation process results in consistent standard curves across lots and across analytes. This is especially important for long-term studies. Standard curve ranges are fixed for the analytes in a panel. Consequently, template setup for one analyte can be used with other analytes in the same panel and across different lots, making data analysis much easier.
Multiplexing is faster and more convenient than ever with MILLIPLEX MAP, providing all the reagents needed, including serum matrix, in an all-one-box format. Customers can choose from an analytically validated panel of analytes to create a custom kit, or they can select a pre-mixed kit.
MILLIPLEX MAP offers the broadest selection of analytes across a wide range of therapeutic areas. For the first time, a single catalog number provides the solution to multiplexing needs in oncology, endocrinology, bone metabolism, metabolic syndrome, cell signaling, and more. Complete assay services complement Millipore’s products at every step of research and development. Combining both products and services from the leaders of multiplexing results in faster and better answers. For more information, click on http://www.millipore.com/milliplex.
Established in 1954 as a high performance filtration products and services company, Millipore has grown into a partner for Life Science customers through R&D investment, organic growth, and acquisitions. Companies acquired include Chemicon®, Upstate®, Linco®, Newport Biosystems, and NovaSeptic® AB. The integrated Millipore offers you more innovative technologies and stronger application support to streamline your process and give you more confidence in your results. Our Drug Discovery business unit has target profiling services, multiplex and traditional immunoassays and clinical lab contract services to help you better understand disease states, prioritize potential drug candidates, screen many biomarkers simultaneously, and conduct research and clinical studies.
About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millpore.com
ADVANCING LIFE SCIENCE TOGETHER™
Research. Development. Production.
Media Contact:
Chandreyee Das
Millipore Corporation
978-762-5147<>chandreyee_das@millipore.com
Millipore, Chemicon, Upstate, Linco, NovAseptic, Beadlyte, and LINCOplex are registered trademarks and MILLIPLEX MAP, the “M” logo, and ADVANCING LIFE SCIENCE TOGETHER are trademarks of Millipore Corporation.
All other trademarks are the property of their respective corporations.

